ro com glp 1 GLP-1 Medications for Weight Loss with the Body Program “I can make it to

For suspected DVT without breathing difficulties, contact your healthcare provider the same day for urgent assessment

SURMOUNT-1 (72-week randomized study, adults without diabetes): tirzepatide produced an average loss of 15.0% (5 mg dose), 19.5% (10 mg dose), and 20.9% (15 mg dose) of body weight, versus 3.1% with placebo, under a similar lifestyle-intervention protocol

Not a flat-rate plan

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis associated with GLP-1RA use compared to usual care

Typical services include: Onboarding playbook for coaches that outlines the patient journey from first contact to ongoing coaching Template messaging for clinic referrals, landing pages, and social posts Patient consent and intake forms prebuilt for GLP-1 workflows Compliance and training modules so you understand safe coaching practices around medication assisted care Analytics dashboard to track patient enrollment, retention, and progress This is the difference between guessing your way through a launch and following a proven, low cost path to scale